SCHEDULE: Disciplined Growth Investors Discloses 10.7% Core Labs Stake

Disciplined Growth Investors, Inc. has filed an amendment to its Schedule 13G, reporting a 10.7% beneficial ownership stake in Core Laboratories Inc.

Summary

• Disciplined Growth Investors, Inc. reported beneficial ownership of 4,937,115 common shares of Core Laboratories Inc.
• This holding represents 10.7% of the total outstanding common shares of the issuer.
• The reporting person maintains sole voting power over 4,653,638 shares and sole dispositive power over 4,937,115 shares.
• The filing is an amendment (No. 6) to a previous Schedule 13G statement.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory filing that confirms existing institutional interest without indicating a change in corporate strategy or financial performance.

Positives

• Institutional investor maintains a significant double-digit equity position, signaling long-term confidence in the issuer.

Negatives

• None identified; this is a standard regulatory disclosure of ownership.

Risks

• None identified; the filing explicitly states the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control.

Future Outlook

The filing does not provide forward-looking guidance, as it is a standard disclosure of institutional share ownership.

Industry Context

StockSavvy.ai notes that institutional ownership filings like Schedule 13G are routine disclosures that provide transparency regarding significant shareholders in the energy services sector, reflecting the investment appetite of asset managers for Core Laboratories' specific market niche.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for institutional investment managers holding over 5% of a public company's equity.

Stakeholder Impact

• Provides transparency to shareholders regarding the concentration of ownership by institutional investors.

Next Steps

• No future actions or milestones are mentioned in this regulatory disclosure.

Key Dates

Keywords

Core Laboratories, Schedule 13G, Disciplined Growth Investors, Institutional Ownership, SEC Filing, Equity Stake